RICHMOND HILL, ONTARIO–(Marketwired – Jan. 5, 2018) – Helix BioPharma Corp. (TSX:HBP)(FRANKFURT:HBP) (“Helix” or the “Company”), an immuno-oncology [...]
VANCOUVER, BRITISH COLUMBIA–(Marketwired – Jan. 5, 2018) – Venzee Technologies Inc. (TSX VENTURE:VENZ) (“Venzee” or the “Company“), a leading provider [...]